- Home
- NERV vs WNW Comparison
NERV vs WNW Comparison
Compare NERV & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NERV | WNW |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2M | 25.8M |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NERV | WNW |
|---|---|---|
| Price | $4.71 | $1.55 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 45.9K | 21.2K |
| Earning Date | 02-24-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.29 |
| Revenue | N/A | ★ $2,550,178.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.12 |
| Revenue Growth | N/A | ★ 570.49 |
| 52 Week Low | $1.15 | $0.95 |
| 52 Week High | $12.46 | $70.00 |
Technical Indicators
Market Signals| Indicator | NERV | WNW |
|---|---|---|
| Relative Strength Index (RSI) | 67.06 | 52.41 |
| Support Level | $3.82 | $1.36 |
| Resistance Level | $4.24 | $1.48 |
| Average True Range (ATR) | 0.29 | 0.10 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 89.56 | 56.79 |
Price Performance
Historical ComparisonAbout NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.